Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Lifeward stock

LFWD
IL0011331076
A12BMB

Price

1.61
Today +/-
-0.02
Today %
-1.23 %

Lifeward stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Lifeward stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Lifeward stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Lifeward stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Lifeward's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Lifeward Stock Price History

DateLifeward Price
12/17/20241.61 undefined
12/16/20241.63 undefined
12/13/20241.65 undefined
12/12/20241.71 undefined
12/11/20241.87 undefined
12/10/20241.87 undefined
12/9/20241.92 undefined
12/6/20241.80 undefined
12/5/20241.88 undefined
12/4/20241.89 undefined
12/3/20241.96 undefined
12/2/20242.14 undefined
11/29/20242.09 undefined
11/27/20242.10 undefined
11/26/20242.06 undefined
11/25/20242.07 undefined
11/22/20241.91 undefined
11/21/20241.86 undefined
11/20/20241.85 undefined
11/19/20241.84 undefined

Lifeward Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Lifeward, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Lifeward from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Lifeward’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Lifeward. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Lifeward’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Lifeward’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Lifeward’s growth potential.

Lifeward Revenue, EBIT and net profit per share

DateLifeward RevenueLifeward EBITLifeward Net Income
2029e212.43 M undefined33.61 M undefined45.29 M undefined
2028e156.59 M undefined28.85 M undefined28.31 M undefined
2027e110.05 M undefined21.14 M undefined13.84 M undefined
2026e76.45 M undefined3.41 M undefined2.07 M undefined
2025e38.25 M undefined-7.93 M undefined-7.77 M undefined
2024e25.91 M undefined-16.99 M undefined-16.71 M undefined
202313.85 M undefined-22.94 M undefined-22.13 M undefined
20225.51 M undefined-19.1 M undefined-19.57 M undefined
20215.97 M undefined-12.66 M undefined-12.74 M undefined
20204.39 M undefined-12 M undefined-12.98 M undefined
20194.87 M undefined-14.05 M undefined-15.55 M undefined
20186.55 M undefined-19.21 M undefined-21.68 M undefined
20177.75 M undefined-21.99 M undefined-24.72 M undefined
20165.87 M undefined-30.44 M undefined-32.5 M undefined
20153.75 M undefined-25.17 M undefined-25.42 M undefined
20143.95 M undefined-19.93 M undefined-23.9 M undefined
20131.59 M undefined-8.75 M undefined-13.84 M undefined
2012972,000 undefined-5.76 M undefined-7.66 M undefined

Lifeward Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
0133576445513253876110156212
--200.00-66.6740.00-14.29-33.33-25.00-160.0092.3152.00100.0044.7441.8235.90
-400.00133.33133.3380.0042.8633.3350.0050.0040.0020.0030.7716.0010.535.263.642.561.89
000003222214000000
-7-13-23-25-32-24-21-15-12-12-19-22-16-72132845
-85.7176.928.7028.00-25.00-12.50-28.57-20.00-58.3315.79-27.27-56.25-128.57550.00115.3860.71
0.070.070.070.070.080.120.210.822.256.858.918.53000000
------------------
Details

Keystats

ⓘ

Revenue and Growth

The Lifeward Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Lifeward is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
201220132014201520162017201820192020202120222023
                       
0.778.9141.8917.9123.6814.579.5516.2520.3588.3467.928.08
0.230.31.962.151.251.10.760.790.680.591.043.12
000000000000
0.560.970.782.533.263.642.243.123.542.992.935.65
0.180.422.371.181.141.630.690.90.670.610.652.37
1.7410.6146.9823.7829.3420.9413.2421.0725.2592.5272.5139.22
0.260.360.411.331.260.840.632.241.791.171.033.12
000000000000
000000000000
0000000000012.53
000000000007.54
0.090.10.270.471.171.091.11.061.031.060.690.78
0.350.450.681.82.431.921.733.32.822.231.7323.97
2.0911.0647.6625.5731.7622.8614.9624.3728.0794.7574.2463.19
                       
000.030.030.050.080.190.51.834.664.494.49
12.4732.5492.494.88114.71134.84154.67178.75201.39278.9279.86281.11
-14.73-26.91-48.57-73.99-106.49-131.22-152.92-168.47-181.45-194.18-213.75-235.88
000000000000
000000000000
-2.265.6343.8520.928.263.711.9410.7821.7789.3870.649.71
0.940.951.392.473.421.812.332.72.271.381.955.07
0.30.560.871.221.020.870.651.311.531.781.853.33
0.190.391.310.650.460.60.680.730.870.870.993.4
68200000000000
00007.56.441.725.440000
2.111.93.574.3412.49.735.3810.174.674.044.7811.8
000010.528.916.971.530000
000000000000
2.253.530.240.310.590.520.671.91.631.331.294.89
2.253.530.240.3111.119.437.643.421.631.331.294.89
4.365.433.814.6523.519.1613.0213.596.295.376.0716.68
2.0911.0647.6625.5731.7622.8614.9624.3728.0794.7576.6766.4
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Lifeward provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Lifeward's financial health and stability.

Assets

Lifeward's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Lifeward must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Lifeward after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Lifeward's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (k)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (k)CASH FLOW FROM OTHER INVESTING ACTIVITIES (k)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201220132014201520162017201820192020202120222023
-6-12-21-25-32-24-21-15-12-12-19-22
000000000001,000
000000000000
000-21-220000-1
036244310010
000012110001
000000000000
-5-8-15-25-26-22-14-14-12-11-17-20
000000000000
00-1,0001,0000000000-18,000
00-1,0001,0000000000-18,000
000000000000
070019-3-3-1-6000
510500151613231679-20
51750033139211679-20
000000007000
000000000000
0832-236-9-56467-20-39
-5.54-8.99-15.49-25.76-27.2-22.48-14.78-14.84-12.66-11.52-17.92-20.75
000000000000

Lifeward stock margins

The Lifeward margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Lifeward. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Lifeward.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Lifeward's sales revenue. A higher gross margin percentage indicates that the Lifeward retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Lifeward's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Lifeward's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Lifeward's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Lifeward. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Lifeward's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Lifeward Margin History

Lifeward Gross marginLifeward Profit marginLifeward EBIT marginLifeward Profit margin
2029e32.14 %15.82 %21.32 %
2028e32.14 %18.43 %18.08 %
2027e32.14 %19.21 %12.57 %
2026e32.14 %4.47 %2.7 %
2025e32.14 %-20.72 %-20.32 %
2024e32.14 %-65.57 %-64.51 %
202332.14 %-165.6 %-159.76 %
202234.57 %-346.62 %-355.09 %
202148.66 %-212.12 %-213.48 %
202049.83 %-273.25 %-295.38 %
201955.94 %-288.28 %-319.13 %
201843.16 %-293.57 %-331.17 %
201740 %-283.66 %-318.81 %
201612.54 %-518.67 %-553.81 %
20155.71 %-672.02 %-678.46 %
2014-15.72 %-504.3 %-604.83 %
2013-27.02 %-550.69 %-871.54 %
2012-1.13 %-592.49 %-788.27 %

Lifeward Stock Sales Revenue, EBIT, Earnings per Share

The Lifeward earnings per share therefore indicates how much revenue Lifeward has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Lifeward earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Lifeward's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Lifeward’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Lifeward's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Lifeward Revenue, EBIT and net profit per share

DateLifeward Sales per ShareLifeward EBIT per shareLifeward Earnings per Share
2029e24.11 undefined0 undefined5.14 undefined
2028e17.77 undefined0 undefined3.21 undefined
2027e12.49 undefined0 undefined1.57 undefined
2026e8.68 undefined0 undefined0.23 undefined
2025e4.34 undefined0 undefined-0.88 undefined
2024e2.94 undefined0 undefined-1.9 undefined
20231.62 undefined-2.69 undefined-2.59 undefined
20220.62 undefined-2.14 undefined-2.2 undefined
20210.87 undefined-1.85 undefined-1.86 undefined
20201.95 undefined-5.33 undefined-5.76 undefined
20195.92 undefined-17.07 undefined-18.9 undefined
201831.17 undefined-91.5 undefined-103.21 undefined
201766.84 undefined-189.59 undefined-213.08 undefined
201678.25 undefined-405.88 undefined-433.37 undefined
201554.29 undefined-364.84 undefined-368.33 undefined
201458.1 undefined-293.01 undefined-351.43 undefined
201324.06 undefined-132.5 undefined-209.7 undefined
201214.73 undefined-87.26 undefined-116.09 undefined

Lifeward business model

Rewalk Robotics Ltd is a publicly traded company specializing in the development and manufacture of exoskeletons that enable individuals with spinal injuries or paralysis to regain mobility. It was founded in 2001 and is based in Marlborough, Massachusetts. The company's goal is to provide individuals with mobility impairments the opportunity for greater freedom of movement and improved quality of life. Rewalk Robotics has launched various products in the field of rehabilitation and industrial applications, and it continues to research and develop new applications for its technology. The exoskeletons use a combination of motors, sensors, and control systems to allow users to stand, walk, and even climb stairs. In addition to medical applications, Rewalk Robotics also provides exoskeletons for industrial use, enhancing worker safety and productivity. The company is actively involved in research and development to expand the therapeutic possibilities of exoskeletons for neurologic conditions such as stroke and Parkinson's disease. Rewalk Robotics is dedicated to innovation and technology, aiming to improve the lives of millions worldwide by providing greater mobility and autonomy. Lifeward is one of the most popular companies on Eulerpool.com.

Lifeward SWOT Analysis

Strengths

1. Leading provider of exoskeleton solutions for individuals with mobility impairments.

2. Established brand in the industry with a strong reputation for innovation and reliability.

3. Extensive intellectual property portfolio, providing a competitive advantage.

Weaknesses

1. High cost of exoskeleton technology limits broader adoption.

2. Relatively limited product range compared to competitors.

3. Dependence on regulatory approvals and reimbursement policies.

Opportunities

1. Increasing global awareness and demand for robotic rehabilitation and assistive devices.

2. Expansion into untapped markets with rising healthcare expenditure and aging populations.

3. Collaborations with healthcare providers and research institutions to further enhance product offerings.

Threats

1. Intense competition from both established companies and startups entering the market.

2. Risk of stricter regulations impacting the approval and reimbursement process.

3. Potential disruption from alternative solutions, such as non-robotic assistive technologies.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Lifeward Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Lifeward historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Lifeward shares outstanding

The number of shares was Lifeward in 2023 — This indicates how many shares 8.531 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Lifeward earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Lifeward's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Lifeward’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Lifeward's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Lifeward stock splits

In Lifeward's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Lifeward.

Lifeward latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/2024-0.32 -0.35  (-8.93 %)2024 Q3
6/30/2024-0.56 -0.5  (10.87 %)2024 Q2
3/31/2024-0.71 -0.73  (-2.24 %)2024 Q1
12/31/2023-0.71 -0.91  (-27.45 %)2023 Q4
9/30/2023-0.79 -0.91  (-15.86 %)2023 Q3
6/30/2023-0.5 -0.56  (-12.04 %)2023 Q2
3/31/2023-0.57 -0.49  (14.22 %)2023 Q1
12/31/2022-0.5 -0.63  (-26.05 %)2022 Q4
9/30/2022-0.43 -0.63  (-47.06 %)2022 Q3
6/30/2022-0.29 -0.49  (-71.57 %)2022 Q2
1
2
3
4

Lifeward shareholders

%
Name
Stocks
Change
Date
16.24411 % The Lind Partners, LLC1,431,10607/24/2024
3.26084 % Kent Lake Capital LLC287,280129,9196/30/2024
1.12321 % LPL Financial LLC98,95598,9556/30/2024
0.66993 % Jasinski (Lawrence J)59,0219,7327/24/2024
0.44842 % Renaissance Technologies LLC39,506-16,5276/30/2024
0.30799 % Turk (Joseph E Jr)27,1342,1287/24/2024
0.29640 % Lawless (Michael A.)26,11313,9287/24/2024
0.29343 % Richner (Randel E.)25,8512,1277/24/2024
0.29011 % Dykan (Jeff)25,5592,1297/24/2024
0.22739 % Poduska (John William Sr)20,0332,1307/24/2024
1
2
3
4
5
...
7

Lifeward Executives and Management Board

Mr. Lawrence Jasinski

(65)
Lifeward Chief Executive Officer, Director (since 2012)
Compensation 927,523

Ms. Jeannine Lynch

(57)
Lifeward Vice President of Market Access and Strategy
Compensation 381,457

Dr. John Poduska

(84)
Lifeward Independent Director
Compensation 94,901

Mr. Jeff Dykan

(63)
Lifeward Independent Chairman of the Board
Compensation 89,704

Mr. Michael Lawless

(55)
Lifeward Chief Financial Officer
1
2

Most common questions regarding Lifeward

What values and corporate philosophy does Lifeward represent?

Rewalk Robotics Ltd represents values of innovation, determination, and commitment to improving the lives of individuals with lower limb disabilities. The company's corporate philosophy revolves around creating advanced robotic exoskeletons that enable individuals to walk again. By incorporating cutting-edge technology and continuous research and development, Rewalk Robotics strives to enhance mobility, increase independence, and improve overall quality of life for its users. Through a strong focus on user-centric design and collaboration with medical professionals, Rewalk Robotics Ltd aims to provide effective and personalized solutions to help individuals regain their independence and reintegrate into society.

In which countries and regions is Lifeward primarily present?

Rewalk Robotics Ltd is primarily present in several countries and regions across the world. The company has a global presence and operates in various key markets, including the United States, Europe, Asia, and beyond. With its cutting-edge assistive technologies for individuals with mobility impairments, Rewalk Robotics Ltd has made significant strides in expanding its reach internationally. The company's commitment to improving the lives of individuals with spinal cord injuries and other mobility challenges has garnered recognition and adoption across different parts of the globe.

What significant milestones has the company Lifeward achieved?

Rewalk Robotics Ltd has achieved several significant milestones since its inception. One of the notable accomplishments is the development and commercialization of their exoskeleton technology, revolutionizing the lives of individuals with lower limb disabilities. The company has successfully obtained regulatory approvals for their innovative designs in various regions, enabling broader market access. Additionally, Rewalk Robotics Ltd has formed strategic partnerships with leading healthcare providers and institutions, fostering collaborations to improve patient outcomes. These milestones highlight the company's commitment to advancing the field of robotics for functional mobility and improving the quality of life for individuals with mobility impairments.

What is the history and background of the company Lifeward?

Rewalk Robotics Ltd is a leading innovative medical device company that designs and develops wearable robotic exoskeletons to help individuals with lower limb disabilities regain their mobility. Founded in 2001, Rewalk Robotics has been dedicated to transforming the lives of people with spinal cord injuries, allowing them to walk again with greater independence. The company's advanced technology combines artificial intelligence, motion sensors, and motorized systems to provide users with enhanced mobility and improved quality of life. Rewalk Robotics has gained global recognition for its groundbreaking solutions and continues to strive for advancements in the field of robotic rehabilitation.

Who are the main competitors of Lifeward in the market?

Rewalk Robotics Ltd faces competition from various companies in the market. Some of its main competitors include Ekso Bionics Holdings, Inc., Parker Hannifin Corporation, and Rex Bionics PLC. These competitors also focus on developing and providing innovative robotic exoskeleton solutions and rehabilitation technologies. However, Rewalk Robotics Ltd continues to stand out by leveraging its unique patented designs and advanced functionalities, catering to the specific needs of individuals with mobility impairments.

In which industries is Lifeward primarily active?

Rewalk Robotics Ltd is primarily active in the healthcare and medical device industry.

What is the business model of Lifeward?

Rewalk Robotics Ltd is a company specializing in the development and commercialization of exoskeleton systems that assist individuals with mobility impairments. Their business model revolves around offering innovative solutions to enhance the quality of life for people with spinal cord injuries, stroke survivors, and other neurological conditions. With a focus on research, development, and production of their robotic exoskeletons, Rewalk Robotics aims to improve mobility, independence, and overall well-being for individuals facing mobility challenges. By combining advanced technology and extensive medical expertise, Rewalk Robotics Ltd strives to be at the forefront of the assistive device industry, providing life-changing solutions for those in need.

What is the P/E ratio of Lifeward 2024?

The Lifeward P/E ratio is -0.82.

What is the P/S ratio of Lifeward 2024?

The Lifeward P/S ratio is 0.53.

What is the Quality Investing of Lifeward?

The Quality Investing for Lifeward is 7/10.

What is the revenue of Lifeward 2024?

The expected Lifeward revenue is 25.91 M USD.

How high is the profit of Lifeward 2024?

The expected Lifeward profit is -16.71 M USD.

What is the business model of Lifeward

Rewalk Robotics Ltd is a leading company in the development of robotics technologies that assist people with reduced mobility capabilities. The company is based in Yokneam, Israel, and was founded in 2001. The company operates in several sectors, including the medical and rehabilitation industry, the military and security industry, and the leisure and entertainment industry. The main product of Rewalk Robotics is the ReWalk Rehabilitation Exoskeleton suit. This state-of-the-art suit allows people with spinal cord injuries to stand and walk again. The suit supports the user's limbs and improves their posture and mobility. The product has been very successful in the medical and rehabilitation industry, as it provides people with greater independence and improved self-confidence. Rewalk Robotics also has a military and security-oriented division. The company is currently developing a range of robots that can be used in emergency situations, disaster relief, or combat zones. The robots can perform tasks such as intercom systems, weapon transport, remote control of vehicles, and much more. This division of the company is rapidly growing and has a lot of potential. Another important area of Rewalk Robotics is the leisure and entertainment industry. The company offers a variety of products that help people with mobility issues to participate in sports and other physical activities. These include racing wheelchairs, adaptive sports clothing, and much more. Rewalk Robotics is known for its innovation and has received a number of awards in recent years. The company is constantly striving to improve its products and has been successful in doing so. It has a broad customer base and works closely with governments, healthcare institutions, and other companies to bring its products to market. Overall, Rewalk Robotics has a successful business model that targets the needs of people with mobility issues. The company has a clear vision and is constantly working to improve its products to achieve the best results. With advancing technology and an increasing demand for mobility solutions, the company has enormous growth opportunities and will play an important role in the future.

What is the Lifeward dividend?

Lifeward pays a dividend of 0 USD distributed over payouts per year.

How often does Lifeward pay dividends?

The dividend cannot currently be calculated for Lifeward or the company does not pay out a dividend.

What is the Lifeward ISIN?

The ISIN of Lifeward is IL0011331076.

What is the Lifeward WKN?

The WKN of Lifeward is A12BMB.

What is the Lifeward ticker?

The ticker of Lifeward is LFWD.

How much dividend does Lifeward pay?

Over the past 12 months, Lifeward paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lifeward is expected to pay a dividend of 0 USD.

What is the dividend yield of Lifeward?

The current dividend yield of Lifeward is .

When does Lifeward pay dividends?

Lifeward pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lifeward?

Lifeward paid dividends every year for the past 0 years.

What is the dividend of Lifeward?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lifeward located?

Lifeward is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lifeward kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lifeward from 12/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did Lifeward pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of Lifeward in the year 2023?

In the year 2023, Lifeward distributed 0 USD as dividends.

In which currency does Lifeward pay out the dividend?

The dividends of Lifeward are distributed in USD.

All fundamentals about Lifeward

Our stock analysis for Lifeward Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lifeward Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.